Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis [NA]
A completed clinical trial evaluating an electrolyzed water spray for mild senile groin eczema, neurodermatitis, and psoriasis; results are …
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab [Phase 2]
Phase 2 trial evaluating apremilast 30 mg twice daily in combination with dupilumab for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models [Phase 4]
Phase 4 trial update focusing on optimizing atopic dermatitis treatment using predictive models to determine the need for second-line system…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children [Phase 3]
Phase 3 clinical trial update on Blue Cap showing efficacy and safety for treating atopic dermatitis in children.
-
FDA approval · 2024-04-10FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Aurobindo Pharma Limited)
FDA approved Betamethasone dipropionate topical from Aurobindo Pharma Limited under an original ANDA for inflammatory and pruritic corticost…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Jaktinib Hydrochloride Cream For Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for jaktinib hydrochloride cream in atopic dermatitis across Phase 1 and Phase 2, with study completed.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy in moderate to severe subacute and chronic atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Dupixent and Narrowband UVB for Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update examining Dupixent in combination with Narrowband UVB for atopic dermatitis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis [Phase 3]
A Phase III extended clinical trial evaluating jaktinib hydrochloride tablets for moderate to severe atopic dermatitis is being conducted, w…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2a study evaluating safety, tolerability, and pharmacokinetics of topically applied PRN473 (SAR444727) in mild-to-moderate atopic derm…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients [Phase 2]
Phase 2 clinical trial update for Hemay808 in atopic dermatitis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Study of Hemay005 in Adult With Atopic Dermatitis [Phase 2]
A Phase 2 trial update for Hemay005 in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children [Phase 4]
Phase 4 study exploring optimal cetirizine dosing for allergic diseases in Chinese children.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis [NA]
Clinical trial update indicates completed study evaluating Cetaphil Restoraderm on young children with atopic dermatitis; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update for MG-K10, a humanized monoclonal antibody, investigated in patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: A Study of MG-K10 in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for MG-K10 in subjects with Atopic Dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating oral difelikefalin as an adjunct to topical corticosteroid for moderate to severe pruritus in atopic dermatitis w…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for 611 in Chinese adults with moderate to severe atopic dermatitis completed.
-
FDA approval · 2024-01-25FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Dupixent (dupilumab) filed by Sanofi‑Aventis U.S. LLC, indicating an approval of a supplement re…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update on SHR-1819 injection for moderate to severe atopic dermatitis assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis [Phase 3]
Phase III clinical trial update for GR1802 injection targeting atopic dermatitis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab [Phase 2]
Phase 2 clinical trial update for Eblasakimab in adults with moderate-to-severe atopic dermatitis who were previously treated with dupilumab…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients [Phase 4]
Phase 4 trial evaluating the impact of dupilumab on quality of life in adults with moderate-to-severe atopic dermatitis. Completed with resu…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the safety and effectiveness of cendakimab (CC-93538) in adults with moderate to severe atopic dermatiti…
-
FDA approval · 2023-12-28FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…